| Literature DB >> 27185795 |
Mathieu Gendrot1, Bécaye Fall2, Marylin Madamet3, Mansour Fall4, Khalifa Ababacar Wade5, Rémy Amalvict3, Aminata Nakoulima6, Nicolas Benoit3, Silman Diawara2, Yaya Diémé2, Bakary Diatta7, Boubacar Wade8, Bruno Pradines9.
Abstract
The RING E3 ubiquitin protein ligase is crucial for facilitating the transfer of ubiquitin. The only polymorphism identified in the E3 ubiquitin protein ligase gene was the D113N mutation (62.5%) but was not significantly associated with the 50% inhibitory concentration (IC50) of conventional antimalarial drugs. However, some mutated isolates (D113N) present a trend of reduced susceptibility to piperaquine (P = 0.0938). To evaluate the association of D113N polymorphism with susceptibility to antimalarials, more isolates are necessary.Entities:
Mesh:
Substances:
Year: 2016 PMID: 27185795 PMCID: PMC4958203 DOI: 10.1128/AAC.03105-15
Source DB: PubMed Journal: Antimicrob Agents Chemother ISSN: 0066-4804 Impact factor: 5.191